This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chip, pharma IPOs need subsidy scrutiny, China antitrust advisor says

By Yonnex Li ( September 5, 2025, 06:37 GMT | Insight) -- A top antitrust advisor to China's State Council, the country's cabinet, is recommending semiconductor and pharmaceutical companies be required to disclose plans for reducing reliance on government subsidies before going public. Huang Yong made the recommendation as part of a broader proposal for China’s next economic blueprint for 2026-2030, a period during which he expects the economy to pivot from scale-driven expansion to quality-focused competition.A top antitrust advisor to China's State Council, the country's cabinet, is recommending semiconductor and pharmaceutical companies be required to disclose how they plan to reduce reliance on government subsidies before going public....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login